Patents by Inventor Larry TIFFANY

Larry TIFFANY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING
    Publication number: 20220133800
    Abstract: The present invention relates to treatment of disease, including treatment of antibody-mediated autoimmune disorders, as well as treatment of other conditions in which antibody therapeutics can be beneficial for targeting destruction of foreign or malignant cells.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: Benjamin M. GREENBERG, Nancy MONSON, Larry TIFFANY
  • TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING
    Publication number: 20210290681
    Abstract: The present invention relates to treatment of disease, including treatment of antibody-mediated autoimmune disorders, as well as treatment of other conditions in which antibody therapeutics can be beneficial for targeting destruction of foreign or malignant cells.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Inventors: Benjamin M. GREENBERG, Nancy MONSON, Larry TIFFANY
  • MATERIALS COMPRISING HYDROPHOBICALLY-MODIFIED BIOPOLYMER
    Publication number: 20200046870
    Abstract: In various aspects, the invention provides materials comprising a hydrophobically-modified biopolymer, such as hm-chitosan, as well as methods of making the materials, including textile materials. The hm-biopolymer can be a polysaccharide and may have antimicrobial properties including against antibiotic-resistant bacteria, providing opportunities to combat microbial persistence in clothing and at wound sites.
    Type: Application
    Filed: October 17, 2017
    Publication date: February 13, 2020
    Inventors: Matthew DOWLING, Larry TIFFANY
  • TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING
    Publication number: 20190183934
    Abstract: The present invention relates to treatment of disease, including treatment of antibody-mediated autoimmune disorders, as well as treatment of other conditions in which antibody therapeutics can be beneficial for targeting destruction of foreign or malignant cells.
    Type: Application
    Filed: May 15, 2017
    Publication date: June 20, 2019
    Inventors: Benjamin M. GREENBERG, Nancy MONSON, Larry TIFFANY